Am­neal Phar­ma's ex­tend­ed-re­lease Park­ison's treat­ment clinch­es FDA ap­proval

Am­neal Phar­ma­ceu­ti­cals’ ex­tend­ed-re­lease cap­sule for Parkin­son’s dis­ease has been ap­proved by the FDA fol­low­ing an ini­tial re­jec­tion last year.

The treat­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA